Glucose-dependent insulinotropic polypeptide (GIP), which reduces appetite and triggers the pancreas to release insulin
It causes symptoms like painful urination and a frequent need to pee
GLP-1s have reached mainstream, and Main Street, status: two in three U.S
"Since starting to inject myself twice a week my life has improved dramatically, I can now walk around the supermarket without feeling on the brink of collapse, I'm using the exercise bike several times a week and many of my symptoms have improved and not just by a small amount," she told GB News
A post-absorptive state ensures digestive demands are not competing with the peptides cellular signaling, allowing for cleaner mitochondrial activation
Retatrutide is given as a once-weekly subcutaneous injection